Симакина Елена Николаевна


Сортировать:

COVID-APR-01 ClinicalTrials.gov

Статус: Unknown status
Фаза: N/A
Начало: 11 июня 2020 г.
Окончание: 31 августа 2020 г.
Описание: The observational study will be carried out in two stages. At the first stage, the efficacy and safety of Aprotinin intravenous infusion as add-on therapy to the standard of care will be studied. At the second stage, two groups will be included: the first group will be the inhaled Aprotinin add-on therapy, the second group will be intravenous Aprotinin in combination with Favipiravir.
смотреть на ClinicalTrials.gov